MedTrace Logo

Laryngeal Mask Ambu Aura Once vs. Supreme in Children

NCT01718782 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-05-15

No results posted yet for this study

Summary

The purpose of this study is determine safety and efficiency of mechanical ventilation in children with two different types of single use laryngeal masks (Ambu AuraOnce vs. LMA Supreme). The main interest is leakage pressure of oropharynx and stomach. The null hypothesis is that leakage pressures of Ambu AuraOnce and LMA Supreme are equivalent. The alternative hypothesis is that there is a difference in leakage pressure.

Conditions

  • Apnea

Interventions

DEVICE

laryngeal mask Ambu AuraOnce

airway management and mechanical ventilation with laryngeal mask

DEVICE

laryngeal mask LMA Supreme

airway management and mechanical ventilation with laryngeal mask

Sponsors & Collaborators

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Peter Paal, MD,DESA,EDIC · University Hospital Innsbruck, Department of Anaesthesia + Intensive Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01718782 on ClinicalTrials.gov